Home / INTI : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does INTI make money? Does INTI have pricing power? What's the Earnings Whisper? Will INTI profit more as the business scales? What is INTI's management track record? Is INTI's current price justified?

Inhibitor Therapeutics, Inc.

$0.1 +$0.05 (+113.22%)

OTC · 14 Sep 2026 20:00 UTC

Previous Close

$0.1

Day Range

$0.09$0.1

Year Range

$0.04$0.12

Market Cap

17.26M

AVG Volume

20.48K

Trailing/Forward PE

-5.24/-

PEG ratio

-1.17

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (USD)

INTI Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	0
26 Q1	0
25 Q4	0
25 Q3	0
25 Q2	0
25 Q1	0
24 Q4	0
24 Q3	0
24 Q2	0
24 Q1	0

Net Income (USD)

INTI Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	-613.93K
26 Q1	-686.42K
25 Q4	-1.3M
25 Q3	-712.18K
25 Q2	-659.94K
25 Q1	-633K
24 Q4	-1.42M
24 Q3	-731K
24 Q2	-502K
24 Q1	-685K

Operating Income (USD)

INTI Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-618.6K
26 Q1	-695.63K
25 Q4	-1.32M
25 Q3	-741.22K
25 Q2	-695.77K
25 Q1	-675K
24 Q4	-1.48M
24 Q3	-813K
24 Q2	-585K
24 Q1	-775K

EBITDA (USD)

INTI EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	-618.6K
26 Q1	-695.63K
25 Q4	-1.32M
25 Q3	-712.18K
25 Q2	-695.77K
25 Q1	-675K
24 Q4	-1.42M
24 Q3	36
24 Q2	-585K
24 Q1	-183

Cash Flows (USD)

INTI Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	-775.22K
26 Q1	-1.08M
25 Q4	-601.16K
25 Q3	-761.25K
25 Q2	-583.99K
25 Q1	-1.28M
24 Q4	-771.44K
24 Q3	-720.44K
24 Q2	-583.08K
24 Q1	-1.16M

EPS (USD)

INTI EPS (USD) by quarter
Period	EPS (USD)
26 Q2	-0
26 Q1	-0
25 Q4	-0.01
25 Q3	-0
25 Q2	-0
25 Q1	-0
24 Q4	-0.01
24 Q3	-0
24 Q2	-0
24 Q1	-0

Expenses (USD)

INTI Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	618.6K
26 Q1	695.63K
25 Q4	1.32M
25 Q3	741.22K
25 Q2	695.77K
25 Q1	674.55K
24 Q4	1.48M
24 Q3	813.2K
24 Q2	585.15K
24 Q1	774.82K

Cash & Debt (USD)

INTI Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	515.76K
26 Q1	1.29M
25 Q4	2.38M
25 Q3	2.98M
25 Q2	3.74M
25 Q1	4.32M
24 Q4	5.61M
24 Q3	6.38M
24 Q2	7.1M
24 Q1	7.68M

Debt ratios

INTI Debt ratios by quarter
Period	Debt ratios
26 Q2	0.14
26 Q1	0.36
25 Q4	0.68
25 Q3	0.83
25 Q2	1.31
25 Q1	1.58
24 Q4	2.79
24 Q3	3.64
24 Q2	4.28
24 Q1	7.16

Margins

INTI Margins by quarter
Period	Margins
18 Q4	100%
18 Q2	100%
18 Q1	100%
17 Q4	100%
17 Q1	100%
15 Q4	100%

Return on Capital

INTI Return on Capital by quarter
Period	Return on Capital
26 Q2	23.99%
26 Q1	34.7%
25 Q4	100.27%
25 Q3	-20625.08%
25 Q2	-92.22%
25 Q1	-46.81%
24 Q4	-71.64%
24 Q3	-21.46%
24 Q2	-12.13%
24 Q1	-14.77%

Shares Outstanding

INTI Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	173.31M
26 Q1	172.57M
25 Q4	172.57M
25 Q3	172.57M
25 Q2	172.57M
25 Q1	172.32M
24 Q4	172.32M
24 Q3	172.32M
24 Q2	172.32M
24 Q1	172.08M

Book Value Per Share (USD)

INTI Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	-0.01
26 Q1	-0.01
25 Q4	-0.01
25 Q3	0
25 Q2	0
25 Q1	0.01
24 Q4	0.01
24 Q3	0.02
24 Q2	0.02
24 Q1	0.03

Total Assets (USD)

INTI Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	637.19K
26 Q1	1.43M
25 Q4	2.51M
25 Q3	3.14M
25 Q2	3.91M
25 Q1	4.51M
24 Q4	5.69M
24 Q3	6.45M
24 Q2	7.17M
24 Q1	7.79M

Employee Count

INTI Employee Count by quarter
Period	Employee Count
2025	2
2024	3
2023	3
2022	3
2021	1
2020	1
2019	2
2018	2
2017	3
2016	3

PE Ratio

INTI PE Ratio by quarter
Period	PE Ratio
Mar 24	1.15
Mar 24	1.12
Mar 24	1.26
Mar 24	1.2
Mar 24	1.15
Feb 24	1.31
Feb 24	1.31
Feb 24	1.15
Feb 24	0.79
Jan 24	1.64
Jan 24	1.63
Jan 24	1.67
Jan 24	1.79
Dec 23	1.51
Dec 23	1.79
Dec 23	1.4
Dec 23	1.08
Dec 23	1.77
Nov 23	1.48
Nov 23	2.43
Nov 23	2.71
Nov 23	1.16
Oct 23	0.81
Oct 23	0.84
Oct 23	0.74
Oct 23	0.74
Sep 23	0.84
Sep 23	0.56
Sep 23	0.84
Sep 23	0.79
Sep 23	0.68
Aug 23	0.79
Aug 23	0.41
Aug 23	0.32
Aug 23	0.47
Jul 23	0.47
Jul 23	0.46
Jul 23	0.44
Jul 23	0.51
Jun 23	0.55
Jun 23	0.54
Jun 23	0.52
Jun 23	0.55
Jun 23	0.47
May 23	0.54
May 23	0.56
May 23	1.17
May 23	0.9
Apr 23	1.05
Apr 23	1.2
Apr 23	0.99
Apr 23	2.96
Mar 23	1.68

Free Cash Flow Yield

INTI Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-18.59%
Sep 26	-18.59%
Sep 26	-25.12%
Aug 26	-20.89%
Aug 26	-20.89%
Aug 26	-22.67%
Aug 26	-29.67%
Jul 26	-21.95%
Jul 26	-20.19%
Jul 26	-22.65%
Jul 26	-22.23%
Jul 26	-22.2%
Jun 26	-19.51%
Jun 26	-20.66%
Jun 26	-20.66%
Jun 26	-22.81%
May 26	-20.66%
May 26	-22.14%
May 26	-21.16%
May 26	-22.55%
May 26	-20.81%
Apr 26	-20.81%
Apr 26	-22.63%
Apr 26	-23.41%
Apr 26	-20.81%
Mar 26	-19.24%
Mar 26	-22.4%
Mar 26	-22.4%
Mar 26	-18.64%
Feb 26	-24.64%
Feb 26	-24.64%
Feb 26	-29.42%
Feb 26	-24.7%
Jan 26	-25.34%
Jan 26	-24.64%
Jan 26	-26.28%
Jan 26	-42.39%
Jan 26	-42.03%
Dec 25	-43.8%
Dec 25	-43.77%
Dec 25	-46.49%
Dec 25	-39.42%
Nov 25	-39.42%
Nov 25	-39.42%
Nov 25	-39.42%
Nov 25	-38.95%
Oct 25	-38.95%
Oct 25	-38.95%
Oct 25	-40.57%
Oct 25	-40.57%
Oct 25	-38.95%
Sep 25	-34.17%
Sep 25	-51.93%
Sep 25	-45.32%
Sep 25	-39.25%
Aug 25	-44.08%
Aug 25	-33.64%
Aug 25	-48.69%
Aug 25	-47.56%
Aug 25	-37.5%
Jul 25	-35.45%
Jul 25	-40.62%
Jul 25	-39%
Jul 25	-40.62%
Jun 25	-41.57%
Jun 25	-45.34%
Jun 25	-39.79%
Jun 25	-36.11%
May 25	-46.48%
May 25	-33.05%
May 25	-34.82%
May 25	-33.44%
May 25	-37.52%
Apr 25	-31.48%
Apr 25	-46.9%
Apr 25	-37.34%
Apr 25	-40.35%
Mar 25	-32.35%
Mar 25	-26.19%
Mar 25	-26.19%
Mar 25	-28.21%
Feb 25	-27.78%
Feb 25	-27.78%
Feb 25	-27.81%
Feb 25	-26.96%
Jan 25	-31.61%
Jan 25	-26.19%
Jan 25	-31.72%
Jan 25	-27.36%
Jan 25	-30.56%
Dec 24	-27.58%
Dec 24	-29.91%
Dec 24	-24.78%
Dec 24	-31.07%
Nov 24	-23.81%
Nov 24	-24.78%
Nov 24	-22.92%
Nov 24	-20.02%
Nov 24	-20.49%
Oct 24	-22.92%

Price to Sales

INTI Price to Sales by quarter
Period	Price to Sales
Mar 20	-2373.24
Mar 20	-2759.58
Mar 20	-3587.45
Mar 20	-4415.33
Feb 20	-4139.37
Feb 20	-4304.94
Feb 20	-3642.65
Feb 20	-4415.33
Jan 20	-3587.45
Jan 20	-3808.22
Jan 20	-3311.5
Jan 20	-3145.92
Jan 20	-2814.77
Dec 19	-3311.5
Dec 19	-2925.15
Dec 19	-2759.58
Dec 19	-2759.58
Nov 19	-2649.2
Nov 19	-772.68
Nov 19	-4304.94
Nov 19	-3311.5
Nov 19	-3366.69
Oct 19	-3366.69
Oct 19	-4028.99
Oct 19	-4028.99
Oct 19	-3311.5
Sep 19	-4801.67
Sep 19	-4801.67
Sep 19	-3587.45
Sep 19	-3311.5
Aug 19	-4746.48
Aug 19	-3477.07
Aug 19	-3587.45
Aug 19	-6141
Aug 19	-5702.36
Jul 19	-5702.36
Jul 19	-5263.71
Jul 19	-7544.66
Jul 19	-7544.66
Jun 19	-7018.29
Jun 19	-7720.11
Jun 19	-6141
Jun 19	-6228.73
May 19	-6404.19
May 19	-7018.29
May 19	-7018.29
May 19	-7106.01
Mar 19	83.26
Feb 19	135.01
Feb 19	112.51
Feb 19	90.01
Feb 19	85.51
Jan 19	70.88
Jan 19	78.76
Jan 19	56.25
Jan 19	56.25
Dec 18	67.51
Dec 18	90.01
Dec 18	168.76
Dec 18	142.89
Nov 18	180.01
Nov 18	202.52
Nov 18	213.77
Nov 18	208.02
Nov 18	312.6
Oct 18	310.35
Oct 18	310.35
Oct 18	269.87
Oct 18	314.85
Sep 18	359.83
Sep 18	348.58
Sep 18	331.71
Sep 18	310.35
Aug 18	306.98
Aug 18	342.96
Aug 18	337.34
Aug 18	335.09
Aug 18	341.83
Jul 18	348.58
Jul 18	339.81
Jul 18	339.81
Jul 18	373.79
Jun 18	362.47
Jun 18	362.47
Jun 18	373.79
Jun 18	339.81
Jun 18	385.12
May 18	328.48
May 18	339.81
May 18	339.81
May 18	305.83
Apr 18	282.38
Apr 18	234.32
Apr 18	291.82
Apr 18	300.41
Mar 18	224.88
Mar 18	224.02
Mar 18	257.49
Mar 18	266.07
Mar 18	240.33

EV/EBITDA

INTI EV/EBITDA by quarter
Period	EV/EBITDA
Mar 24	0.19
Mar 24	0.17
Mar 24	0.29
Mar 24	0.24
Mar 24	0.19
Feb 24	0.33
Feb 24	0.33
Feb 24	0.19
Feb 24	-0.09
Jan 24	0.59
Jan 24	0.59
Jan 24	0.62
Jan 24	0.71
Dec 23	0.49
Dec 23	0.72
Dec 23	0.4
Dec 23	0.14
Dec 23	0.7
Nov 23	0.47
Nov 23	1.24
Nov 23	1.57
Nov 23	0.21
Oct 23	-0.09
Oct 23	-0.06
Oct 23	-0.14
Oct 23	-0.14
Sep 23	-0.06
Sep 23	-0.31
Sep 23	-0.06
Sep 23	-0.11
Sep 23	-0.2
Aug 23	-0.1
Aug 23	-0.43
Aug 23	-0.51
Aug 23	-0.42
Jul 23	-0.42
Jul 23	-0.43
Jul 23	-0.44
Jul 23	-0.38
Jun 23	-0.35
Jun 23	-0.35
Jun 23	-0.38
Jun 23	-0.35
Jun 23	-0.42
May 23	-0.35
May 23	-0.33
May 23	0.21
May 23	-0.05
Apr 23	0.09
Apr 23	0.24
Apr 23	0.03
Apr 23	1.93
Mar 23	0.7

Price/Operating Cashflow

INTI Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Mar 24	1.22
Mar 24	1.19
Mar 24	1.34
Mar 24	1.28
Mar 24	1.22
Feb 24	1.39
Feb 24	1.39
Feb 24	1.22
Feb 24	0.84
Jan 24	1.74
Jan 24	1.73
Jan 24	1.77
Jan 24	1.89
Dec 23	1.6
Dec 23	1.9
Dec 23	1.49
Dec 23	1.15
Dec 23	1.88
Nov 23	1.57
Nov 23	2.58
Nov 23	2.89
Nov 23	1.23
Oct 23	0.86
Oct 23	0.89
Oct 23	0.79
Oct 23	0.79
Sep 23	0.89
Sep 23	0.59
Sep 23	0.89
Sep 23	0.84
Sep 23	0.73
Aug 23	0.84
Aug 23	0.44
Aug 23	0.34
Aug 23	0.5
Jul 23	0.5
Jul 23	0.48
Jul 23	0.47
Jul 23	0.53
Jun 23	0.58
Jun 23	0.58
Jun 23	0.55
Jun 23	0.58
Jun 23	0.5
May 23	0.58
May 23	0.59
May 23	1.2
May 23	0.93
Apr 23	1.08
Apr 23	1.24
Apr 23	1.02
Apr 23	3.05
Mar 23	1.73

Price to Book

INTI Price to Book by quarter
Period	Price to Book
Mar 26	4398.05
Mar 26	4398.05
Mar 26	5283.66
Feb 26	3998.23
Feb 26	3998.23
Feb 26	3348.52
Feb 26	3988.23
Jan 26	3888.28
Jan 26	3998.23
Jan 26	3748.34
Jan 26	2323.97
Jan 26	2343.96
Dec 25	2249
Dec 25	2250.9
Dec 25	2119.06
Dec 25	2498.89
Nov 25	2498.89
Nov 25	2498.89
Nov 25	2498.89
Nov 25	12.06
Oct 25	12.06
Oct 25	12.06
Oct 25	11.58
Oct 25	11.58
Oct 25	12.06
Sep 25	13.75
Sep 25	9.04
Sep 25	10.36
Sep 25	11.97
Aug 25	10.65
Aug 25	13.96
Aug 25	9.65
Aug 25	5.23
Aug 25	6.63
Jul 25	7.01
Jul 25	6.12
Jul 25	6.37
Jul 25	6.12
Jun 25	5.98
Jun 25	5.48
Jun 25	6.24
Jun 25	6.88
May 25	5.35
May 25	7.52
May 25	7.14
May 25	4.87
May 25	4.34
Apr 25	5.17
Apr 25	3.47
Apr 25	4.36
Apr 25	4.04
Mar 25	5.04
Mar 25	3.54
Mar 25	3.54
Mar 25	3.29
Feb 25	3.34
Feb 25	3.34
Feb 25	3.33
Feb 25	3.44
Jan 25	2.93
Jan 25	3.54
Jan 25	2.92
Jan 25	3.39
Jan 25	3.03
Dec 24	3.36
Dec 24	3.1
Dec 24	3.74
Dec 24	2.98
Nov 24	3.89
Nov 24	3.74
Nov 24	4.05
Nov 24	3.62
Nov 24	3.54
Oct 24	3.17
Oct 24	3.33
Oct 24	3.54
Oct 24	3.75
Sep 24	3.22
Sep 24	3.61
Sep 24	2.92
Sep 24	2.87
Aug 24	3.08
Aug 24	3.12
Aug 24	3.33
Aug 24	2.58
Aug 24	2.71
Jul 24	2.6
Jul 24	1.85
Jul 24	3.15
Jul 24	2.97
Jun 24	2.93
Jun 24	2.6
May 24	3.25
May 24	4
May 24	3.3
May 24	3.93
May 24	3.84
Apr 24	2.79
Apr 24	2.23
Apr 24	2.52

No video analysis for this stock yet. Request one from our team.

News: INTI

globenewswire.com · 8 Sep 2026

Inhibitor Therapeutics Highlights Key Developments and Reminds Stockholders of September 15 Annual Meeting

TAMPA, Fla., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Inhibitor Therapeutics, Inc. (OTCQB: INTI) ("Inhibitor" or the "Company") today highlighted several important developments disclosed in its Quarterly Report on Form 10-Q filed August 14, 2026, and encouraged stockholders and other interested parties to review the filing for a more complete discussion of the Company's progress.

AI Analysis

Inhibitor Therapeutics, Inc.

Video analysis: INTI

News: INTI

Inhibitor Therapeutics Highlights Key Developments and Reminds Stockholders of September 15 Annual Meeting

Similar companies